MCM6 promotes metastasis of hepatocellular carcinoma via MEK/ERK pathway and serves as a novel serum biomarker for early recurrence

BACKGROUND: The high incidence of recurrence and metastasis of hepatocellular carcinoma (HCC) necessitate the discovery of new predictive biomarkers of invasion and prognosis. Minichromosome maintenance complex component 6 (MCM6), which has been reported to up-regulate in multiple malignancies, was...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Mingyu, Hu, Qiaoting, Tu, Mengxian, Wang, Xinyi, Yang, Zike, Yang, Guoxiong, Luo, Rongcheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778693/
https://www.ncbi.nlm.nih.gov/pubmed/29357919
http://dx.doi.org/10.1186/s13046-017-0669-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778693/
https://www.ncbi.nlm.nih.gov/pubmed/29357919
http://dx.doi.org/10.1186/s13046-017-0669-z

Ejemplares similares